Neoadjuvant chemotherapy followed by salvage surgery: Effect on survival of patients with primary noncurative gastric cancer

World Journal of Surgery

Volumn 26, Issue 9, 2002, Pages 1155-1159

  Yano, Masahiko ^a   Shiozaki, Hitoshi ^a   Inoue, Masatoshi ^a   Tamura, Shigeyuki ^a   Doki, Yuichiro ^a   Yasuda, Takushi ^a   Fujiwara, Yoshiyuki ^a   Tsujinaka, Toshimasa ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; MITOMYCIN C; PIRARUBICIN; ANTINEOPLASTIC AGENT; DOXORUBICIN; DRUG DERIVATIVE; FEMTX P PROTOCOL; FEMTX-P PROTOCOL; MITOMYCIN; THP FLPM PROTOCOL; THP-FLPM PROTOCOL;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ALOPECIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; GASTROINTESTINAL TOXICITY; HISTOLOGY; HUMAN; LAPAROSCOPY; LAPAROTOMY; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PERITONEUM METASTASIS; PROGNOSIS; SALVAGE THERAPY; STOMACH CANCER; TUMOR BIOPSY; MIDDLE AGED; MORTALITY; PATHOLOGY; PREOPERATIVE CARE; STOMACH TUMOR; SURVIVAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DOXORUBICIN; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; METHOTREXATE; MIDDLE AGED; MITOMYCIN; NEOPLASM STAGING; PREOPERATIVE CARE; PROGNOSIS; SALVAGE THERAPY; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0036715686     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-002-6362-0     Document Type: Article

References (28)

1. Maruyama K. The most important prognostic factors for gastric cancer patients: a study using univariate and multivariate analysis. Scand. J. Gastroenterol. Suppl. 133 1987;22:63-68
2. Nakamura K, Ueyama T, Yao T, et al. Pathology and prognosis of gastric carcinoma: findings in 10,000 patients who underwent primary gastrectomy. Cancer 1992;70:1030-1037
3. Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J. Surg. 1987;11: 418-425
4. Kim JP. Surgical results in gastric cancer. Semin. Surg. Oncol. 1999; 17:132-138
5. Preusser P, Wilke H, Achterrath W, et al. Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer. J. Clin. Oncol. 1989;7:1310-1317
6. Machover D, Goldschmid E, Chollet P, et al. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. J. Clin. Oncol. 1986;4:685-695
7. Wils J, Bleiberg H, Dalesio O, et al. An EORTC Gastrointestinal Group evaluation of the combination of sequential methotrexate and 5-fluorouracil, combined with adriamycin in advanced measurable gastric cancer. J. Clin. Oncol. 1986;4:1799-1803
8. Koizumi W, Kurihara M, Sasai T, et al. A phase II study of combination therapy with 5′-deoxy-5-fluorouridine and cisplatin in the treatment of advanced gastric cancer with primary foci. Cancer 1993;72: 658-662
9. Bleiberg H, Gerad B, Deguiral P. Adjuvant therapy in resectable gastric cancer. Br. J. Cancer 1992;66:987-991
10. Hermans J, Bonenkamp JJ, Boon MC, et al. Adjuvant therapy after curative resection for gastric cancer: metaanalysis of randomized trials. J. Clin. Oncol. 1993;11:1441-1447
11. Douglass HO Jr. Adjuvant therapy of gastric cancer: have we made any progress? Ann. Oncol. 1994;5:S49-57
12. Kelsen DP. Adjuvant and neoadjuvant therapy for gastric cancer. Semin. Oncol. 1996;23:379-389
13. Wilke H, Stahl M, Fink U, et al. Preoperative chemotherapy for unresectable gastric cancer. World J. Surg. 1995;19:210-215
14. Wilke H, Preusser P, Fink U, et al. Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin and cisplatin. J. Clin. Oncol. 1989;7:1318-1326
15. Plukker JT, Mulder NH, Sleijfer DT, et al. Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: phase II study with methotrexate and 5-fluorouracil. Br. J. Surg. 1991;78:955-958
16. Japanese Gastric Cancer Association Japanese classification of gastric carcinoma, 2nd English edition. Gastric Cancer 1998;1:10-24
17. Kelsen DP, Heelan R, Coonley C, et al. Clinical and pathological evaluation of response to chemotherapy in patients with esophageal carcinoma. Am. J. Clin. Oncol. 1983;6:539-546
18. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981;47:207-214
19. Rougier P, Lasser P, Ducreux M, et al. Preoperative chemotherapy of locally advanced gastric cancer. Ann. Oncol. 1994;4(Suppl. 3)59-68
20. Roelofs EJ, Wagener, DJ, Conroy T, et al. Phase II study of sequential high-dose methotrexate (MTX) and 5-fluorouracil (F) alternated with epirubicin (E) and cisplatin (P) [FEMTX-P] in advanced gastric cancer. Ann. Oncol. 1993;4:426-428
21. Yano M, Tsujinaka T, Shiozaki H, et al. Appraisal of treatment strategy by staging laparoscopy for locally advanced gastric cancer. World J. Surg. 2000;24:1130-1136
22. Jaquet P, Sugarbaker P. Peritoneal-plasma barrier. In Sugarbaker PH, editor, Peritoneal Carcinomatosis: Principles of Management, Boston, Kluwer Academic, 1996:53-64
23. Goldie JH. Scientific basis for adjuvant and primary (neoadjuvant) chemotherapy. Semin. Oncol. 1987;14:1-7
24. Graeber TG, Osmanian C, Jacks T, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996;379:88-91
25. Seydel HG, Leichman L, Byhardt R, et al. Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: an RTOG study. Int. J. Radiat. Oncol. Biol. Phys. 1988;14:33-35
26. Forastiere AA, Orringer MB, Perez-Tamayo C, et al. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J. Clin. Oncol. 1993;11:1118-1123
27. Wolfe WG, Vaughn AL, Seigler HF, et al. Survival of patients with carcinoma of the esophagus treated with combined-modality therapy. J. Thorac. Cardiovasc. Surg. 1993;105:749-756
28. Yano M, Tsujinaka T, Shiozaki H, et al. Concurrent chemotherapy (5-fluorouracil and cisplatin) and radiation therapy followed by surgery for T4 squamous cell carcinoma of the esophagus. J. Surg. Oncol. 1999;70:25-32